Priority 4 from the Myeloma (Canada) PSP
|UNCERTAINTY: What are new treatments for myeloma patients that will improve life expectancy with fewer adverse side effects (e.g., pain, nausea, neuropathy, immune suppression)? (JLA PSP Priority 4)
|JLA question ID
|Participants are eager for new treatments at all stages of the disease that will improve the progression-free and overall survival; minimize the side effects of treatment, such as pain, nausea, neuropathy, and immune supression; and improve their quality of life.
No evidence identified
|Health Research Classification System category
|Cancer and neoplasms
|Extra information provided by this PSP
|Original uncertainty examples
|More treatment options are needed, I think, as our doctor says there are only 5 drugs. ~ Can we get a drug that does not cause a multitude of side effects that impact quality of life. ~ life expectancy improvements thru new drug therapy. ~ Create drugs that don't have such awful side effects. ~ Extension of survival through new treatments? ~ Continue research into new therapies and improve therapies and medications that have been successful. ~ Finding treatment meds that don't have to suppress your immune system.
|Please see the PSP Engagement Summary on the JLA website
|PSP unique ID
|Total number of uncertainties identified by this PSP.
|59 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
|Date of priority setting workshop
|28 April 2021